The Heroin Solution by Michigan Law Review
Michigan Law Review 
Volume 83 Issue 4 
1985 
The Heroin Solution 
Michigan Law Review 
Follow this and additional works at: https://repository.law.umich.edu/mlr 
 Part of the Criminal Law Commons, Food and Drug Law Commons, and the Law and Society 
Commons 
Recommended Citation 
Michigan Law Review, The Heroin Solution, 83 MICH. L. REV. 910 (1985). 
Available at: https://repository.law.umich.edu/mlr/vol83/iss4/24 
 
This Review is brought to you for free and open access by the Michigan Law Review at University of Michigan Law 
School Scholarship Repository. It has been accepted for inclusion in Michigan Law Review by an authorized editor 
of University of Michigan Law School Scholarship Repository. For more information, please contact 
mlaw.repository@umich.edu. 
910 Michigan Law Review [Vol. 83:894 
THE HEROIN SOLUTION. By Arnold S. Trebach. New Haven, Conn.: 
Yale University Press. 1982. Pp. xvi, 320. $24.95. 
In America, only criminals take heroin. The mere possession of 
heroin is criminal without exception, and so even doctors who would 
use it for legitimate medical purposes cannot do so. The terribly high 
black-market prices resulting from criminalization force addicts to 
steal in order to buy the drug, and so America is afflicted with a sec-
ond level of illegality - drug-related crime. In The Heroin Solution, 
Arnold S. Trebach argues persuasively that neither of these results of 
heroin's criminalization should be tolerated any longer. He concludes 
that the United States, by making heroin a legal prescription drug as it 
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has long been in Britain, could avoid these results by eliminating their 
cause. 
Much has been written on the addiction problem in the United 
States, but The Heroin Solution takes a somewhat different approach 
than most books on the topic. It is something of a guided tour 
through Professor Trebach's extensive knowledge of the subject, with 
his doubts candidly pointed out along the way to his conclusions. 
Trebach is a professor at the School of Justice of The American Uni-
versity in Washington, D.C. In 1974, he organized the American Uni-
versity's Institute on Drugs, Crime, and Justice in London, and he 
remains its director. In his book, he moves freely back and forth 
across the Atlantic, from scholarly references to his own conversations 
with drug experts, to brief surveys of scientific studies, to personal sto-
ries that sometimes border on the sensational. The reader comes away 
with an appreciation of the tremendous diversity of opinion about her-
oin, and a massive sense of frustration at the inconclusiveness of the 
scientific evidence about the drug. But by relating his own apprecia-
tion of the complexity of these issues, Trebach also imparts a sense of 
the soundness of his conclusions about the problem and its possible 
solutions. He suggests that those who would compare the heroin situ-
ation in England to that in the United States "must ultimately make 
independent judgments based on a review of as much of the original 
evidence as possible" (p. 87). This is also what he offers his readers: a 
huge body of scientific and historical information and a way of inter-
preting it so that an approach often dismissed as preposterous looks 
worthy of a very close second look. 
After establishing that heroin addiction is a serious and worsening 
problem in most of the world, Trebach turns to a subject seldom con-
sidered in popular discussion of heroin legalization: the medical use of 
heroin to treat pain. British doctors routinely use heroin to treat burn 
and heart-attack victims and, most dramatically, cancer patients. The 
conventional American wisdom has been that heroin has no unique 
advantage over morphine in the treatment of organic disease. The sci-
entific results are contradictory, but Trebach presents enough subjec-
tive impressions by doctors to convince the reader that the United 
States may well be sacrificing medical benefits that, in some situations 
and for some patients, only heroin can provide.1 
In light of the British experience, most thoughtful commentators 
would concede that there is no medical reason why heroin should be 
1. In April of 1984, the House Committee on Energy and Co=erce reported favorably on a 
bill that would set up a four-year trial during which heroin would be made available to certain 
hospital and hospice pharmacies and during which doctors would be permitted to prescribe it for 
terminally ill cancer patients only. Professor Trebach was one of eight individuals testifying on 
the bill before the Subcommittee on Health and the Environment. See House Comm. on Energy 
and Commerce, Report to Accompany H.R. 5290, the Compassionate Pain Relief Act, H.R. 
Rep. No. 689, 98th Cong., 2d Sess. (1984). 
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totally unavailable for the treatment of organic disease. Although a 
few fatuous physicians can always be found who will decry the admin-
istration of heroin to terminal cancer patients because of its addictive 
potential, Trebach recognizes that the truly hard questions concern 
the use of heroin to treat addiction itself. It is to the differences be-
tween Britain and America in this regard that he devotes the majority 
of the book. 
Starting from very similar beginnings around the turn of the cen-
tury, Britain and America soon took radically different approaches to 
the regulation of heroin. Trebach starts by examining the develop-
ment of what is usually referred to as the "British system," and his 
message is that it is not a "system" at all. More accurately, it is not 
the centrally-run, top-down bureaucracy that Americans accustomed 
to hearing about British addict registration and socialized medicine 
often expect. Instead, the traditional British approach has been to 
leave the power to prescribe heroin entirely within the discretion of 
individual doctors. Heroin addiction is considered more a medical 
problem than a legal one, and it is for an addict's doctor to decide how 
to treat him. Until recently, doctors could administer other drugs (in-
cluding morphine), wean addicts with gradually diminishing doses of 
heroin, or maintain them on stable doses of inexpensive, pure heroin 
for the rest of their lives.2 Although in recent years British doctors 
have seemed less likely to choose to treat addicts with heroin, British 
law still requires only that doctors who do prescribe heroin or cocaine 
to addicts for treatment of their addiction (but not for treatment of 
organic illness) be specially licensed. The British government does not 
dispense drugs, and addicts have never been "registered." Until re-
cently, private doctors wrote heroin prescriptions entirely free from 
official second-guessing and the fear of prosecution. And until it was 
made mandatory in 1968, doctors "notified" addicts to the Home Of-
fice only as a matter of courtesy;3 the chief use of the information still 
seems to be in compiling the most detailed and complete set of addic-
tion statistics anywhere. 
The American system, on the other hand, is a "system" in the 
grandest bureaucratic tradition. From the time the Harrison Act4 was 
passed in 1914 to ·restrict the use of narcotics to doctors in the course 
of their professional practice, the American medical establishment has 
maintained that there is no legitimate need to use heroin in the prac-
tice of medicine. Instead of fighting for the right to make private med-
ical judgments, as did their British counterparts, most American 
2. The British have always considered the "cold-turkey" sudden-withdrawal method, a hall-
mark of American "treatment" as early as 1926, to be inhumane. P. 91. 
3. Although notification was made mandatory in 1968, it still carries no legal consequences 
for the addict. 
4. Harrison Narcotic Act, Pub. L. No. 63-223, 38 Stat. 785 (1914). 
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doctors supported the efforts of Treasury officials5 who gradually regu-
lated away most of the discretion American doctors had regarding the 
use of heroin. Legal heroin was virtually unavailable in America after 
1924, and the drug was outlawed entirely in 1956. 
Trebach's meticulous argument is probably unnecessary to con-
vince most readers that the American approach to heroin addiction 
has failed. Huge expenditures on enforcement and on methadone 
maintenance programs have proved only that most addicts prefer her-
oin to methadone and that the black market will find ways to satisfy 
this demand at any cost. 6 Looking for a solution, Trebach finds that 
the British approach has, at least until recent years, 7 held addiction 
levels stable and largely removed the impetus to heroin-related crime. 
Meanwhile, on this side of the Atlantic the growing size of federal 
drug busts has been matched, perversely, only by the growing number 
of heroin addicts. 
Trebach's recommendation is that America follow the British 
model, legalizing heroin for medical treatment and keeping the state 
out of the business of deciding what is legitimate medical treatment 
and what is not. As an example of this approach in America, he holds 
up the Shreveport clinic of Dr. Willis Butler, who used opiates suc-
cessfully to treat both organic disease and addiction from 1919 to 
1923. Indeed, if it worked here until the government intervened, and 
worked in Britain for over forty years, why not go back to this ap-
proach? Professor Trebach builds a compelling historical argument 
for the superiority of legalization. Unfortunately, his careful research 
also reveals that British practice today is changing. The legal struc-
ture there is narrowing the scope of doctors' previously unquestioned 
discretion but, perhaps more significantly, British doctors are also vol-
untarily abandoning their previous approach in favor of a very Ameri-
can-looking system. 
Beginning around 1960, the British addiction picture started to 
change. The previously stable addict population began to grow, and 
the new addicts resembled American addicts - young, deviant, and 
5. The Harrison Act was passed as a tax measure in an era when federal power to regulate 
was limited. Trebach notes that several writers, apparently unaccustomed to the convolutions of 
constitutional interpretation, have concluded that the statute was intended by Congress "as a 
revenue and record-keeping measure and nothing more," and was later used by the federal bu-
reaucracy "for its own ends." P. 119. Trebach's careful review of the legislative history leaves 
no doubt that if Congress could have simply outlawed heroin in 1914 as they did in 1956, they 
would have. 
6. Even authors who stop short of Trebach's radical proposals agree with his description of 
the present system's shortcomings. See, e.g .• J. KAPLAN, THE HARDEST DRUG: HEROIN AND 
PUBLIC POLICY (1983) (reviewed at 82 MICH. L. REV. 1032 (1984)). Kaplan concludes that 
there are too many practical problems with heroin maintenance. He recognizes the poor record 
methadone maintenance has had, but suggests that the answer is expanded methadone programs 
with coerced attendance. 
1. See text at note 8 infra. 
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poor - more closely than the traditional British addict, who was often 
an older person who had become addicted through medical treatment 
rather than through recreational use. In response, most British doctors 
were forbidden to prescribe heroin for the treatment of addiction. 8 
Private doctors can still prescribe heroin for the treatment of organic 
illness, and may still administer morphine, methadone, or other nar-
cotics to addicts. But only specially licensed physicians, found almost 
exclusively in drug-treatment clinics, are permitted to treat addicts 
with heroin. Increased regulation, however, is by no means the only 
change. Rather than use their power to continue longstanding prac-
tice, these clinic doctors have moved away from prescribing injectables 
such as heroin, and instead are using oral methadone almost 
exclusively. 
The new British approach, like the old American approach on 
which it is based, does not appear to have solved the problem. Trebach 
does not suggest that this "proves" the efficacy of the approach that 
worked for so long before the British discarded it. He admits that the 
evidence is unclear; in fact, the chapter on Britain today is entitled 
"Doubt and Uncertainty" (p. 171). As with the other controversial 
issues in the book, his approach to the British change of heart is to lay 
out the history of the change and survey the views on both sides of the 
issue. But, for the first time in the book, Professor Trebach's approach 
backfires here; as the title indicates, the reader is left dubious and un-
certain. The facts are simple enough, but Trebach makes little attempt 
to sort out cause from effect, or to address the sociological factors in-
fluencing the change. How much of the medical and legal attitude 
shift is due to the sudden change in the type of addict showing up for 
treatment? How much of the failure of the new British approach is 
due to the change in legal regulations, how much to the new treatment 
methods, and how much to the change in the addicts themselves? Sig-
nificantly, the Shreveport clinic that serves as Trebach's model for the 
future treated a clientele very different from the urban addicts who 
form the majority of modern heroin addicts in America.9 If the Brit-
ish/Shreveport approach does not work with these addicts, either be-
cause societal attitudes will not allow it to work or because there is 
something fundamentally different about the addicts themselves, then 
Professor Trebach's proposal for the future is neither politically practi-
cable nor socially desirable. 
The Heroin Solution lays a thorough groundwork for future discus-
8. At least one author has argued that the change came in response to the new type of addict 
rather than to the increased number of addicts. See P. BEAN, THE SOCIAL CoNTROL OP DRUGS 
113 (1974). For a very detailed treatment of the recent British experience, see DRUG PROBLEMS 
IN BRITAIN: A REVIEW OP TEN YEARS (G. Edwards & C. Busch eds. 1981). 
9. See p. 150. Recent work has shown the importance of addict type to the success of metha-
done-maintenance programs. See, e.g., D. BELLIS, HEROIN AND PoLmCIANS: THE FAILURE 
OP PUBLIC POLICY TO CoNTROL ADDICTION IN AMERICA (1981). 
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sion of heroin maintenance. It brings to the dialogue some ideas that 
laymen, politicians and physicians have generally nof considered wor-
thy of discussion. For instance, consider one British doctor's objection 
to injectable heroin maintenance: "once injecting starts, many addicts 
might be tempted to try other, more destructive drugs" (p. 204). 
Americans may have a hard time picturing heroin as a stepping stone 
to hard drugs. But if we are to fashion a more successful response to 
heroin addiction, we should start looking more closely at the knowl-
edge of the doctors and lawmakers of a nation with far more experi-
ence in the matter than we have. 
Before America adopts anything like the British model of treating 
addicts with doctor-prescribed heroin, we should first be very sure we 
understand the implications of the changes that have occurred in that 
model over the past twenty years. At the same time, the evidence is 
much more convincing on heroin's role in the treatment of organic 
illness; that issue can and should be dealt with separately. With Pro-
fessor Trebach's help, a start has been made in arguing that both the 
organically ill and the addict should have access to prescription her-
oin. But above all, The Heroin Solution is a balanced, exhaustively 
researched contribution to the literature of heroin addiction and its 
treatment. 
